CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Adimmune Corporation Company Snapshot
Adimmune Corporation operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Adimmune with three other companies in this sector in Taiwan: Abnova (Taiwan) Corporation (2018 sales of 426.02 million Taiwanese Dollars [US$13.88 million] of which 27% was Monoclonal Antibodies), Bionet Corp. (770.61 million Taiwanese Dollars [US$25.11 million] ), and Syn-Tech Chem. & Pharm. Co., Ltd. (784.83 million Taiwanese Dollars [US$25.57 million] of which 99% was Sales revenue).

Sales Analysis. Adimmune reported sales of 822.37 million Taiwanese Dollars (US$26.79 million) for the year ending December of 2018. This represents an increase of 46.1% versus 2017, when the company's sales were 562.74 million Taiwanese Dollars. Sales of Finished Products Sales saw an increase of 47.3% in 2018, from 556.82 million Taiwanese Dollars to 820.03 million Taiwanese Dollars. Not all segments of Adimmune experienced an increase in sales in 2018: sales of Semi Finished Products Sales fell 67.3% to 1.61 million Taiwanese Dollars. (However, this segment's sales were only a very small portion of the company's overall sales). Adimmune also experienced decreases in sales in Others Income (down 27.7% to 733,000.00 Taiwanese Dollars) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Adimmune Corporation
  Stock Performance Chart for Adimmune Corporation
 
  Stock Data: Recent Stock Performance:
  Current Price (10/18/2019): 25.75
(Figures in Taiwanese Dollars)
1 Week 1.4%   13 Weeks 2.2%  
4 Weeks 6.6%   52 Weeks 10.8%  
 
Adimmune Corporation Key Data:
  Ticker: 4142 Country: Taiwan
  Exchanges: TAI Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2018 Sales 822,366,000
(Year Ending Jan 2019).
Employees: 386
  Currency: Taiwanese Dollars Market Cap: 9,330,589,750
  Fiscal Yr Ends: December Shares Outstanding: 362,353,000
  Share Type: Gu Closely Held Shares: 90,782,000
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.